Makerere University in collaboration with University of Liverpool received funding from the UK Medical Research Council to build research capacity in Drug Safety Science in Uganda. The goal of this project is to equip and nurture emerging research leaders and professional scholars in Uganda to generate high-quality, contemporary evidence in Drug Safety Science that is translatable into policy and practice. Research modalities span Biomedical Sciences, Clinical Medicine, Epidemiology and Biostatistics, Social Sciences, Implementation Science, and other policy-related disciplines. The project prioritises the fields of pharmacovigilance, pharmacoepidemiology, clinical pharmacology and therapeutics, pharmacogenomics, and clinical disciplines focused on medication use and medication safety.

Applications are invited from ambitious Masters candidates to join our high-impact research project focused on understanding the adverse drug reactions of dolutegravir and isoniazid in people living with HIV in Uganda. We will support graduate students of:

• Makerere University College of Health Sciences
• Mbarara University of Science and Technology
• Gulu University
• Busitema University

The closing date for applications is 31st March 2026.

Enquiries and Applications must be submitted to drugsafetyuganda@gmail.com

Please review the attachment for more information on how to apply.